| Study | Reason for exclusion |
|---|---|
| Ariagno 1987 | Study of late postnatal corticosteroids included in the review "Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Avery 1985 | Study of late postnatal corticosteroids included in the review "Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Brozanski 1995 | Study of late postnatal corticosteroids included in the review "Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| CDTG 1991 | Study of late postnatal corticosteroids included in the review "Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Cummings 1989 | Study of late postnatal corticosteroids included in the review "Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Dobryansky 2012 | 20 VLBW infants were randomised to both hydrocortisone and caffeine as active treatments, compared with "standard guidelines", which presumably meant no hydrocortisone or caffeine. Major outcomes reported included BPD and BPD combined with death. As caffeine reduces BPD (Schmidt 2006), the independent effect of hydrocortisone cannot be determined. |
| Doyle 2006 | Study of late postnatal corticosteroids included in the review "Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Durand 1995 | Study of late postnatal corticosteroids included in the review "Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Gaissmaier 1999 | Primary outcome was need for an epinephrine infusion 12 hours after treatment. No long‐term outcomes reported |
| Gross 2005 | Study of late postnatal corticosteroids included in the review "Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Harkavy 1989 | Study of late postnatal corticosteroids included in the review "Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Kari 1993 | Study of late postnatal corticosteroids included in the review "Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Kazzi 1990 | Study of late postnatal corticosteroids included in the review "Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Kothadia 1999 | Study of late postnatal corticosteroids included in the review "'Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Kovacs 1998 | Study of late postnatal corticosteroids included in the review "Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Noble‐Jamieson 1989 | Study of late postnatal corticosteroids included in the review "Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Ohlsson 1992 | Study of late postnatal corticosteroids included in the review "Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Papile 1998 | Study of late postnatal corticosteroids included in the review "Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Parikh 2013 | Study of late postnatal corticosteroids included in the review "Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Romagnoli 1997 | Study of late postnatal corticosteroids included in the review "Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Salas 2014 | Recruited term infants only for a study of early hydrocortisone to treat hypotension |
| Scott 1997 | Study of late postnatal corticosteroids included in the review "Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Smolkin 2014 | Before after study only ‐ not an RCT |
| Tsukahara 1999 | Not an RCT; 26 study infants and 12 historical controls |
| Vincer 1998 | Study of late postnatal corticosteroids included in the review "'Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Walther 2003 | Study of late postnatal corticosteroids included in the review "Late (> 7 days) systemic postnatal corticosteroids for bronchopulmonary dysplasia in preterm infants" (Doyle 2017) |
| Yaseen 1999 | Study of early dexamethasone, but no outcomes relevant to this review were reported |
BPD: bronchopulmonary dysplasia. RCT: randomised controlled trial. VLBW: very low birth weight.